longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Guardian Pharmacy Services

GRDN

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

    benzinga_article·Sep 23 at 11:49 AM
    TTC-0.95%MRVL-4.39%
  • The Fringe Reality Check: Coupang’s Retail Bleed and Biotech's Psychedelic Bets

    Global Report·Sep 22 at 10:14 AM
    CPNG-1.77%FTFT-7.19%
  • The fragmented narrative beyond big tech: When AI meets LTL freight and super-apps

    Global Report·Sep 16 at 10:13 AM
    GRDN-0.85%MXLL-13.37%
  • Guardian Pharmacy Services, Inc. $GRDN Shares Purchased by Bank of America Corp DE

    Market Beat·Aug 29 at 07:55 AM
    - Bank of America Corp DE increased its position in Guardian Pharmacy Services, Inc. by 86.1 % in the 1st quarter, purchasing an additional 59,245 shares. - Guardian Pharmacy Services reported Q3 earnings of $0.29 per share with revenue of $351.77 million, surpassing analyst expectations. - The company maintains a market capitalization of $1.86 billion and a consensus rating of Moderate Buy among analysts.
    GRDN-0.85%BAC-1.33%
  • Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference | GRDN Stock News

    StockTitan·Aug 19 at 12:30 PM
    GRDN-0.85%
  • Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript

    Motley Fool·Aug 13 at 11:26 PM
    GRDN-0.85%
  • Guardian Pharmacy Services Q2 Earnings Call Highlights

    Market Beat·Aug 8 at 10:03 AM
    GRDN-0.85%
  • Guardian Pharmacy Services, Inc. Stock 12‑Month Price Target Raised to $48.83, Implies 24% Upside

    TradingView·Aug 7 at 09:20 PM
    GRDN-0.85%
  • Guardian Pharmacy Services shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates. Also, Oppenheimer maintained an Outperform rating on the stock and raised its price target from $43 to $49.

    benzinga_article·Aug 7 at 03:11 PM
    GRDN-0.85%
  • Stephens Remains a Buy on Guardian Pharmacy Services, Inc. Class A (GRDN)

    Tip Ranks·Aug 7 at 11:28 AM
    GRDN-0.85%